Skip to content
Open access

Discovery of Highly Potent G Protein-Biased Bisamide Kappa Opioid Receptor Agonists.

Aug 2026 · Journal of Medicinal Chemistry · Vol 69 16, pp. 19779-19807 · 0 citations · 66 references
Medicine

TL;DR

Through a structure-activity relationship (SAR) study of a bisamide-containing lead series, a group of KOR agonists with subnanomolar potency in G protein signaling and several with bias for G protein activation over βarrestin2 recruitment are generated.

Abstract

Kappa opioid receptor (KOR) agonists are used clinically to treat chronic itch and are promising candidates for the treatment of pain and other maladies. Unfortunately, adverse effects have hampered the widespread clinical development of KOR agonists. Preferentially stimulating the G protein activation pathway over the βarrestin2 recruitment pathway has been proposed as a method to minimize adverse effects while maintaining antipruritic and antinociceptive properties. Through a structure-activity relationship (SAR) study of a bisamide-containing lead series, we have generated KOR agonists with subnanomolar potency in G protein signaling and several with bias for G protein activation over βarrestin2 recruitment. A representative member of the series is brain-penetrant and detectable in mouse brain and plasma 60 min post-injection. Based on these in vitro and in vivo results, the SAR explored herein identifies combinations of moieties that produce high-potency and high-bias analogs to further the development of KOR agonists.

Read PDF

Similar papers

Sep 2026

Two-Step Design of Triazole-Stapled Opioid Agonists Exhibiting Potent and Prolonged Peripheral Analgesic Activity.

This study establishes a two-step strategy for developing triazole-stapled multifunctional agonists that integrate opioid and neuropeptide FF (NPFF) pharmacophores. Initially, calcium mobilization assays, enzymatic stability tests, and analgesic activity screens identified triazole-stapled opioid peptide 16, derived fr...

Meng-Na Zhang, Jie Gao, Jia-Min Feng et al. · 0 citations
Conference Open access Aug 2026

Structural differences in the binding of Morphine and TRV130 agonists to the stability of µ-opioid receptor

Computational investigation using molecular docking and molecular dynamics simulations is carried out to differentiate molecular mechanisms involved in the binding of morphine and oliceridine with the µOR receptor, showing that morphine forms persistent hydrogen bonds and electrostatic interactions, whereas TRV130 form...

Cường Tiến Nguyễn, H. T. Lai, T. Tran et al. · 0 citations
Open access Sep 2026

Structural basis of endogenous inverse agonism and subtype selectivity at melanocortin receptors

Cryo-EM structures of melanocortin-1 receptor bound to its endogenous inverse agonist, agouti signaling protein (ASIP) and melanocortin-4 receptor (MC4R) bound to agouti-related protein (AgRP) are reported, establishing a mechanistic framework for endogenous inverse agonism and identifying the receptor periphery as a t...

Qin-Xin Sun, Shu-Hao Zhang, Xin Zhang et al. · 0 citations
Review Open access Oct 2026

Sartans and Bisartans: Expanding Therapeutic Horizons Through Broad Receptor Interactions and Repurposing Potential

Angiotensin receptor blockers (ARBs), also known as sartans, are a family of highly selective angiotensin II type 1 receptor antagonists commonly prescribed to individuals with hypertension, heart failure, and chronic kidney disease. Additionally, the discovery and facile synthesis of bisartans, a novel class of ARB an...

Errikos Petsas, V. Apostolopoulos, Despoina P. Kiouri et al. · 0 citations
Open access Oct 2026

DIFFERENTIAL ACTIVATION OF G-PROTEIN SUBTYPES BY DOPAMINE D1 RECEPTOR ALLOSTERIC MODULATION

Allosteric modulation of G protein-coupled receptors (GPCR) is a rapidly advancing area of drug discovery with considerable therapeutic potential. In this study, we used various bioluminescence resonance energy transfer (BRET) assay configurations to investigate the differential activity of LY3154207, a dopamine D1 rec...

Anh Minh Nguyen, Hayato Umaoka, Hideaki Yano · 0 citations
Open access Oct 2026

Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling

The widespread emergence of ultra-potent synthetic opioids in illicit drug supplies and the limited effectiveness of naloxone in reversing certain synthetic opioid overdoses highlight the urgent need for potent high-affinity opioid antagonists. This study describes an improved synthetic approach and structure-activity...

Z. Hasanpour, Dan Luo, T. Prisinzano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.